Contribution in high quality testing and research in Pharmaceutical, Water testing, Microbiology, Food, Environmental and other areas of Health sciences.
Particularly cost effective drug development and drug testing of Bioavailibility and Bioequivalence studies, IRB/EC approved, ICH/GCP compliant, quality controlled and quality assured studies.
Dow University of Health Sciences (DUHS) has fulfilled the need for facilities to study BA/BE of drugs due to the following requirements in Pakistan.
Pakistan exports drugs worth US $ 200 million per year and these exports may increase further by carrying out BA/BE studies within the country saving also in the expenditure in foreign exchange for these studies abroad by Pakistani pharmaceutical companies.
Drugs worth US $ 85 billion would become off patented during this year becoming Generic and creating huge market for BA/BE studies and Pakistan could get a good share of this business.
World Health Organization (WHO) requires BA/BE studies for procurement of medical products
Health Regulatory Authorities also need these facilities for registration and checking quality of drugs within Pakistan